Share on StockTwits

Stock analysts at Investec upped their target price on shares of Renishaw plc (LON:RSW) from GBX 1,810 ($30.26) to GBX 1,900 ($31.76) in a report issued on Thursday. The firm currently has a “buy” rating on the stock. Investec’s price objective would suggest a potential upside of 13.10% from the stock’s previous close.

Renishaw plc (LON:RSW) remained flat at GBX 1679.9999 during trading on Thursday. 17,570 shares of the company’s stock traded hands. Renishaw plc has a one year low of GBX 1470.00 and a one year high of GBX 2240.00. The stock’s 50-day moving average is GBX 1678. and its 200-day moving average is GBX 1808.68. The company’s market cap is £1.223 billion.

The company also recently declared a dividend, which is scheduled for Monday, October 20th. Shareholders of record on Wednesday, September 17th will be given a dividend of GBX 29.87 ($0.50) per share. This represents a yield of 1.64%. The ex-dividend date of this dividend is Wednesday, September 17th.

Other equities research analysts have also recently issued reports about the stock. Analysts at Credit Suisse reiterated a “neutral” rating on shares of Renishaw plc in a research note on Friday, August 8th. They now have a GBX 1,715 ($28.67) price target on the stock. Separately, analysts at Numis Securities Ltd upgraded shares of Renishaw plc to an “add” rating in a research note on Wednesday, July 23rd. They now have a GBX 1,750 ($29.25) price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Renishaw plc in a research note on Wednesday, July 23rd. They now have a GBX 1,690 ($28.25) price target on the stock. Five research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of GBX 1,847.14 ($30.88).

Renishaw plc is a metrology company. The Company is engaged in the design, manufacture and sale of advanced precision metrology and inspection equipment together with products for the healthcare sector, including Raman spectroscopy systems, dental systems, molecular diagnostic equipment and neurosurgical products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.